2,928
Views
0
CrossRef citations to date
0
Altmetric
Editorials

British Journal of Biomedical Science in 2019. What have we learned?

References

  • Eba A, Raza ST, Abbas M, et al. Association of SDF1β (G801A) and GNB3 (C825T) polymorphisms with the incidence and severity of coronary artery disease. Br J Biomed Sci. 2019;76:49–51.
  • Attallah AM, El-Far M, Abdelrazek MA, et al. Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients. Br J Biomed Sci. 2017;74:170–175.
  • Attallah AM, El-Far M, Ghaly MF, et al. Circulating levels of collagen III and MMP-1 in patients with chronic hepatitis C co-infected with hepatitis B virus. BrJ Biomed Sci. 2017;74:95–100.
  • Attallah AM, Omran D, Omran MM, et al. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients. Br J Biomed Sci. 2018;75:19–23.
  • El-Bendary M, Neamatallah M, Elalfy H, et al. Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection. Br J Biomed Sci. 2019;76:11–16.
  • Arafa M, Besheer T, El-Eraky AM, et al. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients. Br J Biomed Sci. 2019;76:64–69.
  • Badawy AA, El-Rabat A, Elshazly TA, et al. Association of 32-bp deletion polymorphism and promoter methylation of PTEN and hepatitis C virus induced hepatocellular carcinoma. Br J Biomed Sci. 2019;76:195–197.
  • Badawy AA, Othman G, Elabbasy LM, et al. IL-6 −572G/C and −174G/C polymorphisms association with hepatitis C virus-induced hepatocellular carcinoma. Br J Biomed Sci. 2019;76:201–204.
  • Sghaier I, Zidi S, Mouelhi L, et al. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection. Br J Biomed Sci. 2019;76:35–41.
  • Attallah AM, Albannan MS, Omran MM, et al. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis. Br J Biomed Sci. 2019;76:105–110.
  • Tan L, Meng Y, Zeng T, et al. Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy. Br J Biomed Sci. 2019;76:24–28.
  • Lu W, Zhang YP, Zhu HG, et al. Evaluation and comparison of the diagnostic performance of routine blood tests in predicting liver fibrosis in chronic hepatitis B infection. Br J Biomed Sci. 2019;76:137–142.
  • Qin S, Wang J, Zhou C, et al. The severity of NAFLD is associated with the risk of urolithiasis. Br J Biomed Sci. 2019;76:53–58.
  • Elalfy H, El-Maksoud MA, Abed S, et al. Clinicopathological impact of anti-smooth muscle antibodies in patients with non-alcoholic fatty liver disease. Br J Biomed Sci. 2019;76:101–103.
  • Al-Radaideh A, Tayyem R, Al-Fayomi K, et al. The association of hepatic fat percentage with selected anthropometric and biochemical parameters at 3-Tesla magnetic resonance imaging. Br J Biomed Sci. 2019;76:70–76.
  • Tupe RS, Diwan AG, Mittal V, et al. Association of plasma proteins at multiple stages of glycation and antioxidant status with erythrocyte oxidative stress in patients with type 2 diabetes. Br J Biomed Sci. 2014;71:93–99.
  • Watson D, Loweth AC. Oxidative and nitrosative stress in beta-cell apoptosis: their contribution to beta-cell loss in type 1 diabetes mellitus. BrJ Biomed Sci. 2009;66:208–215.
  • Bansal A, Simon MC. Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol. 2018;2217:2291–2298.
  • Kondo T, Hirose M, Kageyama K. Roles of oxidative stress and redox regulation in atherosclerosis. J Atheroscler Thromb. 2009;16:532–538.
  • Banerjee M, Vats P, Kushwah AS, et al. Interaction of antioxidant gene variants and susceptibility to type 2 diabetes mellitus. Br J Biomed Sci. 2019;76:166–171.
  • Osman H, Osman MY, Alsaidy AA. GSTT1, Calpain 10 SNP 19 and indices of glycaemia in type 2 diabetes. Br J Biomed Sci. 2019;76:205–208.
  • Abbas S, Raza ST, Mir S S, et al. No association of SNP 313A→G in GSTP1 with nephropathy, hypertension and dyslipidemia in type 2 diabetes mellitus. Br J Biomed Sci. 2019;76:153–155.
  • Abbas M, Kushwaha VS, Srivastava K, et al. Impact of GSTM1, GSTT1 and GSTP1 genes polymorphisms on clinical toxicities and response to concomitant chemoradiotherapy in cervical cancer. Br J Biomed Sci. 2018;75:169–174.
  • Walia HK, Verma U, Singh N, et al. Polymorphisms in GSTM1 and GSTT1 influence the response and treatment outcome in lung cancer patients treated with platinum-based chemotherapy. BrJ Biomed Sci. 2019;76:198–200.
  • Blann AD. Non-vitamin K antagonist oral anticoagulants (NOACs): a view from the laboratory. Br J Biomed Sci. 2014;71:158–167.
  • Zhang Y, Qian Q, Qian G, et al. Laboratory monitoring of rivaroxaban and assessment of its bleeding risk. Br J Biomed Sci. 2016;73:134–139.
  • Kim B, Jang S, Lee YJ, et al. The rivaroxaban-adjusted normalized ratio: use of the prothrombin time to monitor the therapeutic effect of rivaroxaban. Br J Biomed Sci. 2019;76:122–128.
  • Gopisankar M, Hemachandren M, Surendiran A. ABCB1 2677G>T single nucleotide polymorphism influences warfarin dose requirement for warfarin maintenance therapy. Br J Biomed Sci. 2019;76:150–152.
  • Ünlü B, Versteeg HH. Cancer-associated thrombosis. Thromb Haemost. 2018;2:622–629.
  • Yin J, Zhu SS. Routine coagulation molecules predict nasopharyngeal carcinoma and associated metastases. Br J Biomed Sci. 2019;76:178–183.
  • Kumar S, Gupta E, Srivastava VK, et al. Nitrosative stress and cytokines are linked with the severity of sepsis and organ dysfunction. Br J Biomed Sci. 2019;76:29–34.
  • Orchard GE, Gabriel J, Shams M, et al. Semi–automated standardisation of melanin bleaching procedures of heavily pigmented melanocytic lesions for immunohistochemical analysis on an automated platform. Br J Biomed Sci. 2019;76:172–177.
  • Orchard GE, Wojcik K, Rickaby W, et al. Immunohistochemical detection of V600E BRAF mutation is a useful primary screening tool for malignant melanoma. Br J Biomed Sci. 2019;76:77–82.
  • Warford A, Rahman M, Hughes JA, et al. Pushing the boundaries of in situ hybridisation for mRNA demonstration: demonstration of kappa and lambda light chain restriction in follicular lymphoma. Br J Biomed Sci. 2019;76:143–146.
  • Abbas M, Srivastava K, Imran M, et al. Genetic polymorphisms in DNA repair genes and their association with cervical cancer. Br J Biomed Sci. 2019;76:117–121.
  • Waller P, Blann AD. Non-coding RNAs: A primer for the laboratory Scientist. Br J Biomed Sci. 2019;76:157–165.
  • Fooladinezhad H, Khanahmad H, Ganjalikhani-Hakemi M, et al. Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p. Br J Biomed Sci. 2016;73:129–133.
  • Wang C, Li S, Xu J, et al. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway. Br J Biomed Sci. 2019;76:17–23.
  • Li J, Yu M, Liu Z, et al. Clinical significance of serum miR-25 in non-small-cell lung cancer. Br J Biomed Sci. 2019;76:111–116.
  • Shasttiri A, Delavar MR, Baghi M, et al. SNP rs10800708 within the KIF14 miRNA binding site is linked with breast cancer. Br J Biomed Sci. 2019;76:46–48.
  • Heitmar R, Nicholl P, Lee B, et al. The relationship of systemic markers of haemostasis with retinal blood vessel responses in cardiovascular disease and/or diabetes. Br J Biomed Sci. 2018;75:116–121.
  • Abdullah OA, El Gazzar WB, Salem TI, et al. miR-15a: a potential diagnostic biomarker and a candidate for non-operative therapeutic modality for age-related cataract. Br J Biomed Sci. 2019;76:184–189.
  • Aminian K, Mashayekhi F, Mirzanejad L, et al. A functional genetic variant in GAS5 lncRNA (rs145204276) modulates p27Kip1 expression and confers risk for gastric cancer. Br J Biomed Sci. 2019;76:83–85.
  • Li J, He D. Long noncoding RNA Xist predicts the presence of lymph node metastases in human oesophageal squamous cell carcinoma. Br J Biomed Sci. 2017;74:147–149.
  • Sun BL, Liu X, Gao Y, et al. Downregulation of MiR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients. Br J Biomed Sci. 2016;73:152–157.
  • Ren X, Shen Y, Zheng S, et al. miR-21 predicts poor prognosis in patients with osteosarcoma. Br J Biomed Sci. 2016;73:158–162.
  • Yadegari ZS, Akrami H, Hosseini SV, et al. miR-146a polymorphism and susceptibility to gastric cancer. Br J Biomed Sci. 2016;73:201–203.
  • Liu C, Xing M, Wang L, et al. miR-199a-3p downregulation in thyroid tissues is associated with invasion and metastasis of papillary thyroid carcinoma. Br J Biomed Sci. 2017;74:90–94.
  • Abdul-Maksoud RS, Sediq AM, Kattaia AAA, et al. Serum miR-210 and miR-155 expression levels as novel biomarkers for rheumatoid arthritis diagnosis. Br J Biomed Sci. 2017;74:209–213.
  • Tong X, Wang X, Wang C, et al. Elevated levels of serum MiR-152 and miR-24 in uterine sarcoma: potential for inducing autophagy via SIRT1 and deacetylated LC3. Br J Biomed Sci. 2018;75:7–12.
  • Amr KS, Abdelmawgoud H, Ali ZY, et al. Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease. Br J Biomed Sci. 2018;75:82–87.
  • Hosseinpour Z, Salehi Z, Sasani ST, et al. p53 and miR34b/c genetic variation and their impact on ulcerative colitis susceptibility. Br J Biomed Sci. 2018;75:46–49.
  • Mashayekhi S, Saedi HS, Salehi Z, et al. Effects of miR-27a, mir-196a2 and miR-146a polymorphisms on the risk of breast cancer. Br J Biomed Sci. 2018;75:76–81.
  • Mirnoori SM, Shahangian SS, Salehi Z, et al. Influence of single nucleotide polymorphisms in pri-miR-124-1 and STAT3 genes on gastric cancer susceptibility. Br J Biomed Sci. 2018;75:182–186.
  • Yang F, Zhang H, Ma G, et al. miR-146b measurement in FNA to distinguish papillary thyroid cancer from benign thyroid masses. Br J Biomed Sci. 2018;75:43–45.
  • Dou Y, Li L, Du J, et al. Development of a multiplex two-gene real-time PCR assay for accurate detection of Klebsiella pneumoniae. Br J Biomed Sci. 2019;76:42–45.
  • Mahdavi S, Isazadeh A. Lactobacillus casei suppresses hfq gene expression in Escherichia coli O157:H7. Br J Biomed Sci. 2019;76::92–94.
  • Khatoon J, Prasad KN, Prakash Rai R, et al. Association of heterogenicity of Helicobacter pylori cag pathogenicity island with peptic ulcer diseases and gastric cancer. BrJ Biomed Sci. 2017;74:121–126.
  • Bakhti SZ, Raei N, Latifi-Navid S, et al. Inverse relationship between cagG-positive Helicobacter pylori status and risk of gastric ulcer. Br J Biomed Sci. 2019;76:95–97.
  • Pitt SJ, Graham MA, Dedi CG, et al. Antimicrobial properties of mucus from the brown garden snail Helix aspersa. Br J Biomed Sci. 2019;72:174–181.
  • Pitt SJ, Hawthorne JA, Garcia-Maya M, et al. Identification and characterisation of anti - Pseudomonas aeruginosa proteins in mucus of the brown garden snail, Cornu aspersum. Br J Biomed Sci. 2019;76:129–136.
  • Łucejko M, Tomasiewicz K, Olczak A, et al. Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals. Br J Biomed Sci. 2019;76:190–194.
  • Vidyant S, Chatterjee A, Dhole TN. A single-nucleotide polymorphism in TLR4 is linked with the risk of HIV-1 infection. Br J Biomed Sci. 2019;76:59–63.
  • Sanders D, Fensome-Rimmer S, Woodward B. Uncertainty of measurement in andrology: UK best practice guideline from the Association of Biomedical Andrologists. Br J Biomed Sci. 2019;74:157–162.
  • Long S, Woodward B, Tomlinson M. Sperm toxicity testing: UK best practice guideline from the Association of Biomedical Andrologists. Br J Biomed Sci. 2019;75:53–60.
  • Sabani S, Mashayekhi F, Shahangian SS, et al. Genetic polymorphism of glial cell-derived neurotrophic factor (GDNF) in male infertility. Br J Biomed Sci. 2019;76:86–88.
  • Eslaminejad F, Mashayekhi F, Osalou MA, et al. BMP4 circulating levels and promoter (rs17563) polymorphism in risk prediction of idiopathic male infertility. Br J Biomed Sci. 2019;76:98–100.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.